Senior insider sale
General Counsel and Secretary at ORUKA THERAPEUTICS, INC. — senior position signals high conviction
$7.73M
71.73K shares
What this filing means
QUINLAN PAUL T plans to sell 71.73K shares of ORUKA THERAPEUTICS, INC. valued at approximately $7.73M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/14/2026ACC: 0001950047-26-008164
Officer· General Counsel and Secretary
Since Aug 2024
71.73K
Shares to sell
$7.73M
Approx. market value
71K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
8/14/2026
71KTotal acquired71K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/14/2026 | Exercise of Stock Options Cash | 71K | — |
| Total | 71K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
733.00
Market value
$51.1K
6/15/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
71K
Market value
$7.68M
8/14/2026
Total
Units
71.73K
Value
$7.73M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/15/2026 | 733.00 | $51.1K | — | Completed |
| Planned — Approximate Date | ||||
8/14/2026 | 71K | $7.68M | NASDAQ | Planned |
| Total | 71.73K | $7.73M | ||